biospecimen__admin__batch_number	425.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	F797CEAB-C046-4242-8512-D23FCB143C73
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AAW0-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AAW0-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AAW0-01A
biospecimen__bio__biospecimen_barcode_bottom	0174164314
biospecimen__bio__day_of_creation	10
biospecimen__bio__day_of_shipment	28
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-AAW0.75F8B93A-4839-4A9B-92CD-98147D025D31.pdf
biospecimen__bio__plate_column	11
biospecimen__bio__plate_id	A41H
biospecimen__bio__plate_row	D
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AAW0
biospecimen__shared__patient_id	AAW0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	888A9741-FC40-4FA1-8792-32D4CD626C91
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.3
clinical__chol_lihc_shared__albumin_result_specified_value	4.6
clinical__chol_lihc_shared__albumin_result_upper_limit	5.2
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.2
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.3
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	15
clinical__chol_lihc_shared__fetoprotein_outcome_value	3
clinical__chol_lihc_shared__fibrosis_ishak_score	3,4 - Fibrous Speta
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.8
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Total Hepatectomy with Transplant
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	54
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-AAW0-F67590
clinical__clin_shared__bcr_followup_uuid	DC8194C4-5289-4DCA-B939-FC525CA79D41
clinical__clin_shared__day_of_form_completion	13
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	183
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2009
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	0dac1a36-a034-4c0d-b8e6-021b12b71c9f
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AAW0-01A-11R-A41H-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	42561f2d-d303-4ded-8eb5-b2f2cd29969b
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.88
gdc__analytes__analyte_id	0b7d8a23-6ecf-4079-8c3b-e58a1a6336b5
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	109436aa-a655-429b-8d3b-1a43385c9016
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:31:12.037302-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	9f2f2377-62a0-5f32-bd80-177e1a0a760d
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1955
gdc__diagnoses__age_at_diagnosis	19981
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-19981.0
gdc__diagnoses__days_to_last_follow_up	2015.0
gdc__diagnoses__diagnosis_id	3cd21457-69d0-5e94-b9b7-592e532574e6
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	25.35154137371552
gdc__exposures__exposure_id	c3ac8073-cac3-5310-9c76-df6a5d39d16e
gdc__exposures__height	172.0
gdc__exposures__weight	75.0
gdc__file_id	759c9a20-3456-4466-ace6-a929c63a6239
gdc__file_name	45f7ed20-6d17-4bbd-b526-bf0a7f3a30f3.mirbase21.mirnas.quantification.txt
gdc__file_size	50302
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	0531e662279c3a68c232a5b568cf4125
gdc__portions__is_ffpe	false
gdc__portions__portion_id	85ac0981-3953-4414-9a63-f4ada4773366
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1737
gdc__samples__initial_weight	70.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	75F8B93A-4839-4A9B-92CD-98147D025D31
gdc__samples__sample_id	c7da1402-2958-469e-9956-395c03833125
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	3.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	688331fc-0b27-4adf-83df-33ce26c61cdd
gdc__submitter_id	mirna_swap_dr11_103_MirnaExpressiondb94e14a-269e-4c16-b963-cbfa576dd23f_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	34a5a14d-59c9-5469-9be9-8e137e3986c1
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:04.390+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/0dac1a36-a034-4c0d-b8e6-021b12b71c9f-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/0dac1a36-a034-4c0d-b8e6-021b12b71c9f-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129673
manually_curated__local_md5	045c6719201e3afe9041a814e5706633
manually_curated__opengdc_download_date	2018-10-16T17:11:28.000785+02:00
manually_curated__opengdc_file_md5	8f5eaca60a1c662debca08e7fc4f48b7
manually_curated__opengdc_file_size	50301
manually_curated__opengdc_id	0dac1a36-a034-4c0d-b8e6-021b12b71c9f-meq
manually_curated__origin_file_size	129673
manually_curated__origin_last_modified_date	Tue Oct 16 17:44:00 CEST 2018
manually_curated__origin_md5	045c6719201e3afe9041a814e5706633
manually_curated__tissue_status	tumoral
